R Hawkins1, A S Shatil1, L Lee2, A Sengupta1, L Zhang1, S Morrow3, R I Aviv4,5. 1. From the Department of Medical Imaging (R.H., A.S.S., A.S., L.Z.). 2. Division of Neurology (L.L.), Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 3. Division of Neurology (S.M.), Lawson Health Research Institute, London Health Sciences Centre, University Hospital, London, Ontario, Canada. 4. Institute of Biomaterials and Biomedical Engineering (R.I.A.), University of Toronto, Toronto, Ontario, Canada raviv@toh.ca. 5. Department of Radiology (R.I.A.), University of Ottawa, and Division of Neuroradiology, The Ottawa Hospital, Ottawa, Ontario, Canada.
Abstract
BACKGROUND AND PURPOSE: Graph theory uses structural similarity to analyze cortical structural connectivity. We used a voxel-based definition of cortical covariance networks to quantify and assess the relationship of network characteristics to cognition in a cohort of patients with relapsing-remitting MS with and without cognitive impairment. MATERIALS AND METHODS: We compared subject-specific structural gray matter network properties of 18 healthy controls, 25 patients with MS with cognitive impairment, and 55 patients with MS without cognitive impairment. Network parameters were compared, and predictive value for cognition was assessed, adjusting for confounders (sex, education, gray matter volume, network size and degree, and T1 and T2 lesion load). Backward stepwise multivariable regression quantified predictive factors for 5 neurocognitive domain test scores. RESULTS: Greater path length (r = -0.28, P < .0057) and lower normalized path length (r = 0.36, P < .0004) demonstrated a correlation with average cognition when comparing healthy controls with patients with MS. Similarly, MS with cognitive impairment demonstrated a correlation between lower normalized path length (r = 0.40, P < .001) and reduced average cognition. Increased normalized path length was associated with better performance for processing (P < .001), learning (P < .001), and executive domain function (P = .0235), while reduced path length was associated with better executive (P = .0031) and visual domains. Normalized path length improved prediction for processing (R 2 = 43.6%, G2 = 20.9; P < .0001) and learning (R 2 = 40.4%, G2 = 26.1; P < .0001) over a null model comprising confounders. Similarly, higher normalized path length improved prediction of average z scores (G2 = 21.3; P < .0001) and, combined with WM volume, explained 52% of average cognition variance. CONCLUSIONS: Patients with MS and cognitive impairment demonstrate more random network features and reduced global efficiency, impacting multiple cognitive domains. A model of normalized path length with normal-appearing white matter volume improved average cognitive z score prediction, explaining 52% of variance.
BACKGROUND AND PURPOSE: Graph theory uses structural similarity to analyze cortical structural connectivity. We used a voxel-based definition of cortical covariance networks to quantify and assess the relationship of network characteristics to cognition in a cohort of patients with relapsing-remitting MS with and without cognitive impairment. MATERIALS AND METHODS: We compared subject-specific structural gray matter network properties of 18 healthy controls, 25 patients with MS with cognitive impairment, and 55 patients with MS without cognitive impairment. Network parameters were compared, and predictive value for cognition was assessed, adjusting for confounders (sex, education, gray matter volume, network size and degree, and T1 and T2 lesion load). Backward stepwise multivariable regression quantified predictive factors for 5 neurocognitive domain test scores. RESULTS: Greater path length (r = -0.28, P < .0057) and lower normalized path length (r = 0.36, P < .0004) demonstrated a correlation with average cognition when comparing healthy controls with patients with MS. Similarly, MS with cognitive impairment demonstrated a correlation between lower normalized path length (r = 0.40, P < .001) and reduced average cognition. Increased normalized path length was associated with better performance for processing (P < .001), learning (P < .001), and executive domain function (P = .0235), while reduced path length was associated with better executive (P = .0031) and visual domains. Normalized path length improved prediction for processing (R 2 = 43.6%, G2 = 20.9; P < .0001) and learning (R 2 = 40.4%, G2 = 26.1; P < .0001) over a null model comprising confounders. Similarly, higher normalized path length improved prediction of average z scores (G2 = 21.3; P < .0001) and, combined with WM volume, explained 52% of average cognition variance. CONCLUSIONS:Patients with MS and cognitive impairment demonstrate more random network features and reduced global efficiency, impacting multiple cognitive domains. A model of normalized path length with normal-appearing white matter volume improved average cognitive z score prediction, explaining 52% of variance.
Authors: W Staffen; A Mair; H Zauner; J Unterrainer; H Niederhofer; A Kutzelnigg; S Ritter; S Golaszewski; B Iglseder; G Ladurner Journal: Brain Date: 2002-06 Impact factor: 13.501
Authors: Betty M Tijms; Alle Meije Wink; Willem de Haan; Wiesje M van der Flier; Cornelis J Stam; Philip Scheltens; Frederik Barkhof Journal: Neurobiol Aging Date: 2013-03-28 Impact factor: 4.673
Authors: Alan J Thompson; Brenda L Banwell; Frederik Barkhof; William M Carroll; Timothy Coetzee; Giancarlo Comi; Jorge Correale; Franz Fazekas; Massimo Filippi; Mark S Freedman; Kazuo Fujihara; Steven L Galetta; Hans Peter Hartung; Ludwig Kappos; Fred D Lublin; Ruth Ann Marrie; Aaron E Miller; David H Miller; Xavier Montalban; Ellen M Mowry; Per Soelberg Sorensen; Mar Tintoré; Anthony L Traboulsee; Maria Trojano; Bernard M J Uitdehaag; Sandra Vukusic; Emmanuelle Waubant; Brian G Weinshenker; Stephen C Reingold; Jeffrey A Cohen Journal: Lancet Neurol Date: 2017-12-21 Impact factor: 44.182
Authors: Betty M Tijms; Emma Sprooten; Dominic Job; Eve C Johnstone; David G C Owens; David Willshaw; Peggy Seriès; Stephen M Lawrie Journal: Schizophr Res Date: 2015-08-30 Impact factor: 4.939
Authors: Mariella Gregorich; Federico Melograna; Martina Sunqvist; Stefan Michiels; Kristel Van Steen; Georg Heinze Journal: BMC Med Res Methodol Date: 2022-03-06 Impact factor: 4.615
Authors: Elisabet Lopez-Soley; Elisabeth Solana; Eloy Martínez-Heras; Magi Andorra; Joaquim Radua; Albert Prats-Uribe; Carmen Montejo; Nuria Sola-Valls; Maria Sepulveda; Irene Pulido-Valdeolivas; Yolanda Blanco; Elena H Martinez-Lapiscina; Albert Saiz; Sara Llufriu Journal: Front Neurol Date: 2020-10-30 Impact factor: 4.003